← Open Payments lookup

GINGER MCMILLIAN: Open Payments

NPI 1306237664 · MONTGOMERY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$387 in 16 payments from 12 companies in 2025. Trend: 2023 $280 · 2024 $362 · 2025 $387

Food & beverage: $288Education: $99
CompanyPaymentsAmount
Astellas Pharma US Inc1$99
PFIZER INC.3$76
AstraZeneca Pharmaceuticals LP3$47
MAYNE PHARMA COMMERCIAL LLC1$31
Novo Nordisk Inc1$24
Currax Pharmaceuticals LLC1$17
Amgen Inc.1$17
Cranial Technologies, Inc1$17
Otsuka America Pharmaceutical, Inc.1$16
Axsome Therapeutics, Inc.1$15

Products named: PREVNAR 20, AIRSUPRA, NURTEC ODT, Ozempic, CONTRAVE, OTEZLA, Doc Band, FARXIGA.

Industry payments across TX — which companies pay providers there.